“…Use of PCSEMS in the treatment of benign diseases is controversial due to the adverse events described during their removal [3,9,17,21,[26][27][28][29][30]. These adverse events may include: hemorrhage, granulation or hyperplasic tissue ingrowth, obstruction, stent fracture, penetration, perforation, avulsion, fistula formation (i.e., tracheoesophageal, esophagoaortic, pericardioesophageal), and epidural abscess formation [1,3,11,17,19,28,[31][32][33][34][35][36][37].…”